Showing all 7 results
A 20mg Retatrutide research cartridge, reconstituted for consistent precision.
– eight 2.5mg doses or twenty 1mg doses
- Purity Pen compatible
– For research use only
A 20mg Retatrutide research cartridge, reconstituted for consistent precision.
– eight 2.5mg doses or twenty 1mg doses
– Purity Pen compatible
– For research use only
Semaglutide is a GLP-1 receptor agonist used to improve blood sugar control and promote weight loss by enhancing satiety and slowing gastric emptying.
– 10mg per vial
– Lyophilized powder
– ≥99% purity
– For research use only
Semaglutide is a GLP-1 receptor agonist used to improve blood sugar control and promote weight loss by enhancing satiety and slowing gastric emptying.
– 10mg per vial
– Lyophilized powder
– ≥99% purity
– For research use only
Semaglutide is a GLP-1 receptor agonist used to improve blood sugar control and promote weight loss by enhancing satiety and slowing gastric emptying.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Semaglutide is a GLP-1 receptor agonist used to improve blood sugar control and promote weight loss by enhancing satiety and slowing gastric emptying.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
High-purity GLP-1 + Tirz peptide compound
– 10mg per vial
– Lyophilized powder
– ≥99% purity
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
High-purity GLP-1 + Tirz peptide compound
– 10mg per vial
– Lyophilized powder
– ≥99% purity
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials.
– 10mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials.
– 10mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 20mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 20mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
